Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CureVac N.V.
  6. News
  7. All News
    CVAC   NL0015436031

CUREVAC N.V.

(CVAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about CUREVAC N.V.
11/30GSK names Pfizer scientist Dormitzer as vaccines R&D head
RE
11/19CureVac's Q3 Pretax Loss Widens, Revenue Rises
MT
11/19CureVac To Begin Trials Of COVID-19 Vaccine As Animal Testing Shows Strong Antibody Res..
MT
11/18CureVac to begin trials for next-generation COVID-19 shots within months
RE
11/18CUREVAC N : Announces Financial Results for the Third Quarter and First Nine Months of 202..
PU
11/18CUREVAC N : Announces Financial Results for the Third Quarter and First Nine Months of 202..
PU
11/18CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2021..
EQ
11/18CureVac Says Preclinical Trial Shows Antibody Levels of COVID-19 Vaccine Candidate CV2C..
MT
11/18CUREVAC N : Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, ..
PU
11/18CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, ..
EQ
11/18CureVac N.V. Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candida..
CI
11/10CureVac Says CV8102 Phase 1 Study's Dose-Escalation Part Shows Immune Response Against ..
MT
11/10CureVac Presents Promising Data at SITC from Phase 1 Study of Oncology Candidate CV8102..
PU
11/10CureVac Presents Promising Data at SITC from Phase 1 Study of Oncology Candidate CV810..
EQ
11/10CureVac N.V. Presents Promising Data at SITC from Phase 1 Study of Oncology Candidate C..
CI
10/22CUREVAC N : Deutsche Bank Starts CureVac at Hold with $35 Price Target
MT
10/18CUREVAC N : Shareholder dievini Files Shareholding Change with US Regulator; Stock Down 5%
MT
10/15CureVac Shares Down 12%
DJ
10/13CUREVAC N : EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by Cur..
AQ
10/12CLOSE UPDATE : US Stocks Waver Ahead of Earnings, FOMC Minutes; Investors Remain Cautious ..
MT
10/12Health Care Stocks Extending Retreat Ahead of Tuesday Close
MT
10/12Equities Choppy Midday as Clarida Says Fed Would Respond to Rise in Inflation Expectati..
MT
10/12MIDDAY REPORT : US Stocks Choppy as Clarida Says Fed Would Respond to Rise in Inflation Ex..
MT
10/12Health Care Stocks Falling Despite Moderate Rise Among Biotech Companies
MT
10/12CUREVAC N : Drops COVID-19 Vaccine to Focus on Second-Generation Shot with GlaxoSmithKline
MT
10/12Wall Street Set for Cautiously Higher Open, Earnings Season Eyed
MT
10/12Health Care Stocks Edge Higher Premarket Tuesday
MT
10/12WALL STREET STOCK EXCHANGE : It's just a period of market normalization
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
PU
10/12CUREVAC N : Forgoes COVID-19 Vaccine Candidate; Stock Slips 15%
MT
10/12CUREVAC N : to Refocus COVID-19 Vaccine Development Efforts to Second-Generation mRNA Cand..
MT
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
PU
10/12CUREVAC N : to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techn..
EQ
10/12CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Techno..
CI
09/28Sanofi ditches mRNA COVID-19 vaccine after rivals' success
RE
09/28Sanofi ditches mRNA COVID-19 vaccine after rivals' success
RE
09/23MODERNA : EU drugs regulator to decide on Pfizer vaccine booster in early October
RE
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated; Rentschle..
PU
09/14APPLE : U.S. stocks close lower on worries over recovery, corporate tax hikes
RE
09/14INTUIT : Wall Street dips as choppy recovery, looming tax hikes weigh on sentiment
RE
09/14CUREVAC N : Terminates Two Manufacturing Contracts Amid Streamlining of European mRNA Prod..
MT
09/14Health Care Stocks Rally Early Tuesday
MT
09/14CUREVAC N : Terminates 2 Manufacturing Contracts Amid Streamlining of European mRNA Produc..
MT
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
PU
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
EQ
09/14CureVac Streamlines European Network for mRNA Product Manufacturing
CI
09/14CureVac Shares Fall Premarket on Termination of Vaccine Contracts With Wacker Chemie, C..
DJ
09/14CureVac Terminates Covid Vaccine Manufacturing Contract With Wacker Chemie, Celonic -- ..
DJ
08/31Health Care Stocks Add to Early Slide
MT
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet (Form 6-K)
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
EQ
08/31CureVac N.V.'s CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
CI
08/30CUREVAC N : Preclinical Data Shows Sharp Reduction of Liver Fibrosis With mRNA Therapeutic..
MT
08/30CUREVAC N : Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRN..
PU
08/30CUREVAC N : Findings in preclinical mouse models provide first direct proof of efficacy of..
PU
08/30CUREVAC N : Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRN..
EQ
08/30CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA..
CI
08/18CUREVAC N : Bionity - CureVac's Second-Generation Vaccine Candidate Demonstrates Improved ..
AQ
08/16CUREVAC N : GlaxoSmithKline's Next-Generation COVID-19 Vaccine Shows Improved Animal Immun..
MT
08/16CUREVAC N : Earnings Flash (CVAC) CUREVAC Posts Q2 Revenue EUR22.4M
MT
08/16GLAXOSMITHKLINE : GSK, CureVac's next-gen COVID-19 vaccine shows promise in monkey trial
RE
08/16SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Monday
MT
08/16GLAXOSMITHKLINE : CureVac's Second-Generation COVID-19 Vaccine Candidate Shows Potential i..
MT
08/16SECTOR UPDATE : Health Care
MT
08/16CUREVAC N : GlaxoSmithKline's Second-Generation COVID-19 Vaccine Candidate Shows Potential..
MT
08/16GLAXOSMITHKLINE : GSK, CureVac say their COVID-19 vaccine shows promise in monkey trial
RE
08/16CUREVAC N : Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improv..
PU
08/16CUREVAC N : Announces Financial Results for the Second Quarter and First Half of 2021 and ..
PU
08/16CUREVAC N : Announces Financial Results for the Second Quarter and First Half of 2021 and ..
PU
08/16Curevac N.V. Announces Unaudited Consolidated Financial Results for the Second Quarter ..
CI
08/16CureVac Announces that Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demon..
CI
08/16CUREVAC N : Announces Financial Results for the Second Quarter and First Half of 2021 and ..
EQ
1  2  3  4  5Next
Upcoming event on CUREVAC N.V.